Logo image of CRDL

CARDIOL THERAPEUTICS INC-A (CRDL) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:CRDL - CA14161Y2006 - Common Stock

1.02 USD
0 (0%)
Last: 1/22/2026, 2:28:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRDL revenue by date.CRDL revenue by date.
80K
-100.00%
12.99M52.313M
302.72%
115.77M
121.30%
251.93M
117.61%
357.97M
42.09%
526.58M
47.10%
680.47M
29.22%
EBITDA
YoY % growth
CRDL ebitda by date.CRDL ebitda by date.
-13.98M
-99.43%
-20.46M
-46.35%
-38.44M
-87.88%
-24.48M
-6.97%
-23.46M
28.17%
-32.773M
-35.10%
-30.806M
22.80%
-24.012M
22.05%
-21.18M
11.79%
-21.581M
-1.89%
10.865M
150.34%
59.046M
443.45%
158.77M
168.89%
260.99M
64.38%
310.58M
19.00%
EBIT
YoY % growth
CRDL ebit by date.CRDL ebit by date.
-14.13M
-99.01%
-20.69M
-46.43%
-38.66M
-86.85%
-39.79M
-6.93%
-29.07M
27.95%
-40.494M
-35.22%
-36.006M
10.60%
-31.81M
11.65%
-15.975M
49.78%
18.378M
215.05%
81.262M
342.17%
187.3M
130.49%
223.48M
19.32%
315.84M
41.33%
373.85M
18.37%
Operating Margin
CRDL operating margin by date.CRDL operating margin by date.
N/AN/A-48,325.00%N/AN/AN/AN/AN/A-122.98%35.13%70.19%74.35%62.43%59.98%54.94%
EPS
YoY % growth
CRDL eps by date.CRDL eps by date.
N/AN/A
12.54%
N/A
-10.14%
-0.54
8.50%
-0.44
10.20%
-0.55
-15.91%
-0.40
22.00%
-0.57
-42.74%
-0.16
72.46%
0.08
149.17%
0.51
566.45%
1.31
155.86%
1.04
-21.07%
1.70
64.07%
2.03
19.53%

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.08
9.33%
-0.11
-12.20%
-0.11
-12.20%
-0.11
6.50%
-0.11
-37.50%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-10.506M
-5.17%
-9.894M
-17.38%
-10.2M
-32.88%
-10.71M
-5.21%
-11.322M
-7.77%

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.12
33.33%
-0.09-0.03-30.72%
Q2 2025
Q2Q % growth
-0.10 -0.120.0218.30%
Q1 2025
Q2Q % growth
-0.10
28.57%
-0.140.0429.97%
Q4 2024
Q2Q % growth
-0.09
25.00%
-0.130.0432.64%
Q3 2024
Q2Q % growth
-0.18
-100.00%
-0.12-0.06-47.06%
Q2 2024
Q2Q % growth
-0.10
16.67%
-0.130.0324.59%
Q1 2024
Q2Q % growth
-0.14
-27.27%
-0.13-0.01-5.58%
Q4 2023
Q2Q % growth
-0.12 -0.120.001.96%
Q3 2023
Q2Q % growth
-0.09
30.77%
-0.120.0326.47%
Q2 2023
Q2Q % growth
-0.12
-20.00%
-0.130.015.88%
Q1 2023
Q2Q % growth
-0.11
21.43%
-0.150.0428.10%
Q4 2022
Q2Q % growth
-0.12
-9.09%
-0.160.0424.10%
Q3 2022
Q2Q % growth
-0.13
8.96%
-0.150.0212.10%
Q2 2022
Q2Q % growth
-0.10
37.50%
-0.140.0429.97%
Q1 2022
Q2Q % growth
-0.14
46.15%
-0.170.0319.26%
Q4 2021
Q2Q % growth
-0.11
26.67%
-0.150.0428.10%
Q2 2021
Q2Q % growth
-0.16 -0.14-0.02-12.04%
Q1 2021
Q2Q % growth
-0.26
-136.36%
-0.14-0.12-82.07%
Q4 2020
Q2Q % growth
-0.15 -0.12-0.03-22.55%
Q1 2020
Q2Q % growth
-0.11 -0.160.0532.60%
CRDL Yearly EPS VS EstimatesCRDL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 -0.5 1 1.5 2
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q2 2022
Q2Q % growth

-100.00%
%
Q3 2021
Q2Q % growth
306K-306K-100.00%
Q2 2021
Q2Q % growth
80K 204K-124K-60.78%
Q1 2021
Q2Q % growth
51K-51K-100.00%
Q4 2020
Q2Q % growth
255K-255K-100.00%
CRDL Yearly Revenue VS EstimatesCRDL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -14.29% 0% -6.85%
RevenueN/A N/A N/A N/A